IL186935A0 - Prostate cancer field effect analysis methods and kits - Google Patents
Prostate cancer field effect analysis methods and kitsInfo
- Publication number
- IL186935A0 IL186935A0 IL186935A IL18693507A IL186935A0 IL 186935 A0 IL186935 A0 IL 186935A0 IL 186935 A IL186935 A IL 186935A IL 18693507 A IL18693507 A IL 18693507A IL 186935 A0 IL186935 A0 IL 186935A0
- Authority
- IL
- Israel
- Prior art keywords
- kits
- field effect
- prostate cancer
- analysis methods
- effect analysis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85564006P | 2006-10-31 | 2006-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL186935A0 true IL186935A0 (en) | 2008-02-09 |
Family
ID=38969822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL186935A IL186935A0 (en) | 2006-10-31 | 2007-10-25 | Prostate cancer field effect analysis methods and kits |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1918711A3 (en) |
JP (1) | JP2008113659A (en) |
KR (1) | KR20080039323A (en) |
CN (1) | CN101270388A (en) |
BR (1) | BRPI0705819A (en) |
CA (1) | CA2606589A1 (en) |
IL (1) | IL186935A0 (en) |
MX (1) | MX2007013726A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102016067A (en) * | 2008-01-22 | 2011-04-13 | 维里德克斯有限责任公司 | Detection of GSTP1 hypermethylation in prostate cancer |
WO2010017301A1 (en) * | 2008-08-05 | 2010-02-11 | Veridex, Llc | Prostate cancer methylation assay |
ATE547403T1 (en) | 2008-08-15 | 2012-03-15 | Univ Georgetown | FLUORESCENT REGULATORS OF RASSF1A EXPRESSION AND HUMAN CANCER CELL PROLIFERATION |
US11053255B2 (en) | 2015-06-22 | 2021-07-06 | Georgetown University | Synthesis of mahanine and related compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
GB9609441D0 (en) | 1996-05-04 | 1996-07-10 | Zeneca Ltd | Process |
GB9812768D0 (en) | 1998-06-13 | 1998-08-12 | Zeneca Ltd | Methods |
CA2438943C (en) * | 2001-02-23 | 2019-05-14 | Dana-Farber Cancer Institute, Inc. | Hin-1, a tumor suppressor gene |
EP1456413B1 (en) * | 2001-11-16 | 2008-04-23 | The Johns Hopkins University School Of Medicine | Method of detection of prostate cancer |
-
2007
- 2007-10-25 IL IL186935A patent/IL186935A0/en unknown
- 2007-10-30 EP EP07254302A patent/EP1918711A3/en not_active Withdrawn
- 2007-10-30 JP JP2007282156A patent/JP2008113659A/en active Pending
- 2007-10-31 BR BRPI0705819-5A patent/BRPI0705819A/en not_active Application Discontinuation
- 2007-10-31 KR KR1020070110469A patent/KR20080039323A/en not_active Application Discontinuation
- 2007-10-31 CN CNA2007103061543A patent/CN101270388A/en active Pending
- 2007-10-31 CA CA002606589A patent/CA2606589A1/en not_active Abandoned
- 2007-10-31 MX MX2007013726A patent/MX2007013726A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2007013726A (en) | 2009-02-19 |
BRPI0705819A (en) | 2008-06-24 |
KR20080039323A (en) | 2008-05-07 |
CA2606589A1 (en) | 2008-04-30 |
EP1918711A3 (en) | 2008-07-09 |
JP2008113659A (en) | 2008-05-22 |
CN101270388A (en) | 2008-09-24 |
EP1918711A2 (en) | 2008-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2074422A4 (en) | Methods and kits for detecting prostate cancer biomarkers | |
EP2061899A4 (en) | BIOMARKERS OF PROSTATE CANCER AND METHODS USING THEM | |
EP1922326A4 (en) | Biomarkers useful for diagnosing prostate cancer, and methods thereof | |
EP2156184A4 (en) | Methods for diagnosing and treating prostate and lung cancer | |
ZA200901615B (en) | Compositions and methods for diagnosing and treating cancer | |
HK1140944A1 (en) | Methods and compositions for treating recurrent cancer | |
EP2032166A4 (en) | Compositions and methods for diagnosing and treating cancer | |
EP2069523A4 (en) | Methods and devices for analyzing small rna molecules | |
GB0603295D0 (en) | Methods and kits | |
PL2173379T3 (en) | Compositions and methods for treating and diagnosing cancer | |
ZA201101132B (en) | Signatures and pcdeterminants associated with prostate cancer and methods of use thereof | |
EP2073728A4 (en) | Biopsy devices and related methods | |
GB0521521D0 (en) | Diagnostic methods and kits | |
EP2125887A4 (en) | Compositions and methods for diagnosing and treating cancer | |
EP2155249A4 (en) | Compositions and methods for diagnosing and treating cancer | |
EP1977247A4 (en) | Methods for diagnosing and treating prostate cancer | |
PL1858929T3 (en) | Diagnosis of prostate cancer | |
IL186980A0 (en) | Characterizing prostate cancer | |
ZA200705280B (en) | Cancer markers and detection methods | |
EP2099491A4 (en) | Compositions and methods for diagnosing and treating cancer | |
GB0618429D0 (en) | Cancer test | |
EP2137213A4 (en) | Methods and compositions for treating prostate cancer | |
IL186935A0 (en) | Prostate cancer field effect analysis methods and kits | |
EP2146208A4 (en) | Kit for deciding degree of malignancy in prostate cancer and method of using the same | |
SG10201701286YA (en) | Cancer detection methods and techniques |